Leo Pharma brings in old friends and new blood for eczema treatment launch
![Monica Shaw, an Executive Vice President, Head of Europe, Canada and Australia at Leo Pharma | Photo: Leo Pharma / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13143600.ece/ALTERNATES/schema-16_9/doc7gqjihmwqyaigklwn85.jpg)
Leo Pharma is making the most of its EU approval for eczema treatment Adtralza (tralokinumab) coming in two weeks earlier than expected.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Ascendis moves forward with phase III drug
For subscribers